Laboratory Solutions for I-O and CDx Development

A podcast series on I-O clinical development testing

Q2 Solutions is a premier global central laboratory service provider for I-O clinical development testing. With a global central laboratory network including a footprint in the Americas, Europe, Asia-Pacific, and China, a breadth of technological expertise and harmonized processes is available across the laboratories.

In our new Immuno-Oncology podcast series, Q2 Solutions scientists and subject matter experts discuss our innovative immunotherapy laboratory services that combine scientific expertise, innovative technologies, and industry relationships. Listen to each episode below.

  1. Episode 1 – Introduction and Overview with Patrice Hugo, Chief Scientific Officer
  2. Episode 2 - BioAnalytical Quantitation and Immunogenicity Testing with Michael Brown, Immunoanalytical Scientific Director 

Episode 3
Episode 4
Episode 5

Learn more about our integrated Immuno-Oncology solutions.
T-cell Receptor (TCR) Sequencing Assay for Characterization of Adaptive Immune Response

Detects TCRβ and TCRγ clonotypes expressed at the mRNA level

Microsatellite Instability Assay for Response to Immunotherapy

MSI assay for sensitive detection of 5 mononucleotide repeat markers in tumor FFPE specimens

Read More